NRX Pharmaceuticals (NRXP) Q1 2025 Earnings

17MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.75
-0.55
-0.35
-0.15

Details

Expected EPS
-0.366667
Actual EPS
-0.7243
Surprise EPS
-0.36
Surprise Percent
+97.54%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.7243 per share for Q1 2025.

0 Comments

Share your thoughts